Alice Zhang

Chief Executive Officer and Co-founder

Therapeutic Areas

Drug	Indication	Phase
VRG50635 (VRG635)	Amyotrophic Lateral Sclerosis (ALS)	Phase 1
Peripheral CD38 Program	Parkinson's Disease	Discovery
VRG201	Obesity	Discovery
Target-03	ALS	Discovery
Target-04	ALS	Discovery
Unnamed Program	Frontotemporal Dementia	Discovery